Targeting the apoptosome for cancer therapy

Clinical Cancer Research

Volumn 15, Issue 2, 2009, Pages 420-424

  Ledgerwood, Elizabeth C ^a   Morison, Ian M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CASPASE 3; CYTOCHROME C; FAS LIGAND; PROCASPASE 9; TUMOR NECROSIS FACTOR;

APOPTOSIS; CANCER THERAPY; CATALYSIS; CELL STRESS; COMPLEX FORMATION; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

ADENOSINE DIPHOSPHATE; ANIMALS; APOPTOSIS; APOPTOSOMES; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASES; CELL-FREE SYSTEM; CYTOCHROMES C; CYTOSOL; ENZYME ACTIVATION; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 59449110529     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1172     Document Type: Review

References (70)

1. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008;9:231 -41.
2. Jiang X, Wang X. Cytochrome C - mediated apoptosis. Annu Rev Biochem 2004;73:87-106.
3. Ow YL, Green DR. Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 2008;9:532-42.
4. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86:147-57.
5. Barinaga M. Death by dozens of cuts. Science 1998; 280:32-4.
6. Ekert PG, Vaux DL. The mitochondrial death squad: hardened killers or innocent bystanders? Curr Opin Cell Biol 2005;17:626-30.
7. Cain K. Chemical-induced apoptosis: formation of the Apaf-1 apoptosome. Drug Metab Rev 2003:35: 337-63.
8. Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007;8: 405-13.
9. Bao Q, Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ 2007;14: 56-65
10. Benedict MA, HuY, Inohara N, Nún̊tez G. Expression and functional analysis of Apaf-1 isoforms. J Biol Chem 2000:275:8461 -8.
11. Yu X, Acehan D, Menetret JF, et al. A structure of the human apoptosome at 12.8 Å resolution provides insights into this cell death platform. Structure 2005; 13:1725-35.
12. Purring C, Zou H, Wang X, McLendon G. Stoichiometry, free energy, and kinetic aspects of cytochrome c: Apaf-1 binding in apoptosis. J Am Chem Soc 1999; 121:7435.
13. Abdullaev Z, Bodrova ME, Chernyak BV, et al. A cytochrome c mutant with high electron transfer and antioxidant activities but devoid of apoptogenic effect. Biochem J 2002;362:749-54.
14. Yu T. Wang X, Purring-Koch C. Wei Y, McLendon GL. A mutational epitope for cytochrome c binding to the apoptosis protease activation factor-1. J Biol Chem 2001;276:13034-8.
15. Kluck RM, Ellerby LM, Ellerby HM, et al. Determinants of cytochrome c pro-apoptotic activity. J Biol Chem 2000;275:16127-33.
16. Chandra D, Bratton SB, Person MD, et al. Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome c and inhibiting apoptosome. Cell 2006;125:1333-46.
17. Morison IM, Cramer-Bordé EM, Cheesman EJ, et al. A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia. Nat Genet 2008;40:387-9.
18. Jemmerson R, Liu J, Hausauer D, Lam K-P, Mondino A, Nelson RD. A conformational change incytochrome c of apoptotic and necrotic cells is detected by monoclonal antibody binding and mimicked by association of the native antigen with synthetic phospholipid vesicles. Biochemistry 1999;38: 3599-609.
19. Sinibaldi F, Mei G, Polticelli F, et al. ATP specifically drives refolding of non-native conformations of cytochrome c. Protein Sci 2005;14:1049-58.
20. Hu Y, Ding L, Spencer DM, Nún̄ez G. WD-40 repeat regulates Apaf-1 self-association and procaspase-9 activation. J Biol Chem 1998;273:33489-94.
21. Kim HE, Du F, Fang M.Wang X. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci U S A 2005;102:17545-50.
22. Purring-Koch C, McLendon G. Cytochrome c binding to Apaf-1: the effects of dATP and ionic strength. Proc Natl Acad Sci U S A 2000;97:11928-31.
23. Cain K, Langlais C, Sun X-M, Brown DG, Cohen GM. Physiological concentrations of K+ inhibit cytochrome c - dependent formation of the apoptosome. J Biol Chem 2001;276:41985-90.
24. Segal M, Beem E. Effect of pH, ionic charge, and osmolality of cytochrome c - mediated caspase activation. Am J Physiol 2001;281:C1196-204.
25. Hampton MB, Zhivotovsky B, Slater AFG, Burgess DH, Orrenius S. Importance of the redox state of cytochrome c during caspase activation in cytosolic extracts. Biochem J 1998;329:95-9.
26. Bao Q, Lu W. Rabinowitz JD, Shi Y Calcium blocks formation of apoptosome by preventing nucleotide exchange in Apaf-1. Mol Cell 2007;25:181 -92.
27. Hughes FM, Jr., Bortner CD, Purdy GD, Cidlowski JA. Intracellular K+ supresses the activation of apoptosis in lymphocytes. J Biol Chem 1997;272:30567-76.
28. Bortner CD, Hughes FM, Jr., Cidlowski JA. A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem 1997;272:32436-42.
29. Pan G, O'Rourke K, Dixit VM. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem 1998:273:5841 -5.
30. Hu Y, Benedict MA. Wu D, Inohara N, Nún̊ez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf- 1-dependent caspase-9 activation. Proc Natl Acad Sci USA1998;95:4386-91.
31. Moriishi K, Huang DCS, Cory S, Adams JM. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proc Natl Acad Sci U S A 1999;96:9683-8.
32. Twiddy D, Brown DG, Adrain C, et al. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J Biol Chem 2004;279:19665-82.
33. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ. Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 2004;23:2134-45.
34. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of theApaf-1 apoptosome by Hsp70. Nat Cell Biol 2000;2:476-83.
35. Beere HM, Wolf BA, Cain K, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000;2:469-75.
36. Steel R, Doherty JP, Buzzard K, Clemons N, Hawkins CJ, Anderson RL. Hsp72 inhibits apoptosis upstream of the mitochondria and not through interactions with Apaf-1. J Biol Chem 2004;279: 51490-9.
37. Bruey J-M, Ducasse C, Bonniaud P, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000, 2:645-52.
38. Pandey P, Saleh A, Nakazawa A, et al. Negative regulation of cytochrome c - mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 2000;19:4310-22.
39. Kurokawa M, Zhao C, Reya T, Kornbluth S. Inhibition of apoptosome formation by suppression of Hsp90β phosphorylation in tyrosine kinase-induced leukemias. Mol Cell Biol 2008;28:5494-506.
40. Jiang X, Kim H-E, Shu H-B, et al. Distinctive roles of PHAP proteins and prothymosin-α in a death regulatory pathway. Science 2003;299:223-6.
41. Kim HE, Jiang X, Du F, Wang X. PHAPI, CAS, and Hsp70 promote apoptosome formation by preventing Apaf-1 aggregation and enhancing nucleotide exchange on Apaf-1. Mol Cell 2008;30:239-47.
42. Malicet C, Giroux V. Vasseur S, Dagorn JC, Neira JL, lovanna JL. Regulation of apoptosis by the p8/prothymosin α complex. Proc Natl Acad Sci U S A 2006; 103:2617-76.
43. Markova OV, Evstafieva AG, Mansurova SE, et al. Cytochrome c is transformed from ami- to pro-oxidant when interacting with truncated oncoprotein prothymosin α. Biochim Biophys Acta 2003;1557: 109-17.
44. Schafer ZT, Kornbluth S. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 2006;10:549-61.
45. Schonhoff C, Gaston B, Mannick JB. Nitrosylation of cytochrome c during apoptosis. J Biol Chem 2003;278:18265-70.
46. Suto D, Sato K, Ohba Y, Yoshimura T, Fujii J. Suppression of the pro-apoptotic function of cytochrome c by singlet oxygen via a haem redox state-independent mechanism. Biochem J 2005;392:399-406.
47. Hanahan D, EWeinberg RA. The hallmarks of cancer. Cell 2000;100:57 - 70.
48. Fischer U, Janssen K, Schulze-Osthoff K. Cutting- edge apoptosis-based therapies. Biodrugs 2007:21: 273-97.
49. D'Amelio M, Tino E, Cecconi F. The apoptosome: emerging insights and new potential targets for drug design. Pharm Res 2008;25:740 - 51.
50. Fadeel B, Ottosson A, Pervaiz S. Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance. Cell Death Differ 2008;15:443-52.
51. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002;108:153-64.
52. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004;9:691 -704.
53. Soengas MS, Capodieci P, Polsky D, et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001;409:207-11.
54. Fujimoto A, Takeuchi H, Taback B, et al. Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma. Cancer Res 2004;64:2245-50.
55. Baldi A, Santini D, Russo P, et al. Analysis of APAF- 1 expression in human cutaneous melanoma progression. Exp Dermatol 2004;13:93-7.
56. Allen JD, Zhang XD, Scott CL, Boyle GM, Hersey P, Strasser A. Is Apaf-1 expression frequently abrogated in melanoma? Cell Death Differ 2005;12:680-1.
57. Peltenburg LT, de Bruin EC, Meersma D, Smit NP, Schrier PI, Medema JP. Expression and function of the apoptosis effector Apaf-1 in melanoma. Cell Death Differ 2005;12:678-9.
58. Jia L, Srinivasula SM, Liu F-T, et al. Apaf-1 protein deficiency confers resistance to cytochrome c -dependent apoptosis in human leukemic cells. Blood 2001;98:414-21.
59. Wolf BB, Schuler M, Li W-G, et al. Defective cytochrome c - dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem 2001; 276:34244-51.
60. WatanabeT, HirotaY, ArakawaY, et al. Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma. Brain Pathol 2003;13:431 -9.
61. Schimmer AD, Pedersen IM, Kitada S, et al. Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy. Cancer Res 2003:63: 1242-8.
62. Sun Y Orrenius S, Pervaiz S, Fadeel B. Plasma membrane sequestration of apoptotic protease- activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance. Blood 2005; 105:4070-7.
63. Hoffarth S, Zitzer A. Wiewrodt R, et al. pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer. Cell Death Differ 2008;15:161 -70.
64. Huerta S, Heinzerling JH, Anguiano-Hernandez Y-M, et al. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NF-κB, IAPs, Smac/Diablo, and AIF J Surg Res 2007;142: 184-94.
65. Mashima T, Oh-hara T, Sato S, et al. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target. J Natl Cancer Inst 2005;97:765-77.
66. Schafer ZT, Parrish AB, Wright KM, et al. Enhanced sensitivity to cytochrome c - induced apoptosis mediated by PHAP1 in breast cancer cells. Cancer Res 2006;66:2210-8.
67. Johnson CE, Huang YY, Parrish AB, et al. Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci U S A 2007;104:20820-5.
68. Wright KM, Linhoff MW, Potts PR. Deshmukh M. Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis. J Cell Biol 2004;167:303-13.
69. Nguyen JT, Wells JA. Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc Natl Acad Sci U S A 2003; 100:7533-8.
70. Wang S, Yan-Neale Y, Cai R, Alimov I, Cohen D. Activation of mitochondrial pathway is crucial for tumor selective induction of apoptosis by LAQ824. Cell Cycle 2006;5:1662-8.